Similar to the results of AMPKα, high expression levels of FOXO3a were correlated with a good prognosis in GC patients treated with a 5-FU-based regimen (204132_s_at) (Fig. 6h, i; Supplementary Fig. S6b–g). Here, FOXO3 is linked to gastric cancer.